Clinical Trial

Clinical Evaluation of a New Platform for Bi-manual Endoscopic Resection in the Rectum and Sigma (EndoTEM)

Study acronym: EndoTEM
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to determine whether the use of the EndoTEM system during the endoscopic removal of polyps in the distal colon is feasible and safe. The main questions it aims to answer are: * Is the use of the EndoTEM system during the endoscopic removal of polyps in the distal colon feasible (i.e., does it enable complete resection of the polyp)? * Is the use of the EndoTEM system during the endoscopic removal of polyps in the distal colon safe? Participants will: * be treated with the EndoTEM system during the endoscopic submucosal dissection of polyps in the distal colon. * answere questionnaires on fecal continence and quality of life before and after the intervention. * be treated following standard clinical procedures before, during and after the endoscopic removal.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-21.
Status change: Not Yet Recruiting → Recruiting 2026-03-30
Trial Details
NCT Number NCT07146165
Lead Sponsor Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
Collaborators: Ovesco Endoscopy AG, Tuebingen Scientific Medical GmbH
Conditions Adenoma Colon Polyp, Adenoma Colon
Enrollment 30 participants
Start Date 2025-10-02
Primary Completion 2028-08 (estimated)
Study Completion 2028-08 (estimated)
Updated on ClinicalTrials.gov 2026-03-31